je.st
news
Tag: clinical
St. Jude Researcher Honored by the American Society of Clinical...
2014-05-30 20:41:14| Logistics - Topix.net
The American Society of Clinical Oncology has named Leslie L. Robison, Ph.D., of St. Jude Children's Research Hospital the recipient of the 2014 Pediatric Oncology Award for his contributions to the field of childhood cancer survivorship research.
Tags: american
society
clinical
researcher
NIH: Online Pain Eval and Care Module Helps Improve Clinical Skills
2014-05-24 18:17:25| Biotech - Topix.net
A news release issued by the National Institutes of Health announces that a recent report indicates an online training module, built for the evaluation and care of chronic pain, "greatly" improved medical student clinical skills.
Tags: online
care
improve
skills
endpoint Introduces PULSE(TM) 3.0 Platform for IRT Systems in Clinical Trials
2014-05-22 06:00:00| Industrial Newsroom - All News for Today
SAN FRANCISCO, -- PULSE enables highly customized IRT trial design while maintaining endpoint's signature 30-Day delivery timeline<br /> <br /> endpoint Clinical, Inc., a leading provider of Interactive Response Technology (IRT) systems via phone (IVRS), web (IWRS) and mobile (IMRS) for global clinical trials, today announced the launch of its next-generation PULSE 3.0 platform. The enhanced PULSE platform provides highly customized configuration and deployment of complex trial designs in a ...This story is related to the following:Clinical Trial Management Software |
Tags: systems
platform
clinical
trials
ImmunoGen, Inc. Announces Clinical Data Presentations at Upcoming 50th Annual Meeting of ASCO
2014-05-15 18:18:39| Logistics - Topix.net
New clinical data are being presented on ImmunoGen wholly owned compounds, IMGN529 and IMGN853, as well as on partner compounds SAR3419, SAR650984 and Kadcyla .
AiCuris and Merck Announce Publication in New England Journal of Medicine of Phase 2 Clinical Trial Results of Investigational Antiviral Agent Letermovir in Bone Marrow Transplant Patients
2014-05-08 15:00:00| Merck.com - Research & Development News
Dateline City: WUPPERTAL, Germany & WHITEHOUSE STATION, N.J. WUPPERTAL, Germany & WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--AiCuris and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the publication of results from a Phase 2 clinical trial evaluating the safety and efficacy of letermovir, an investigational, oral antiviral agent for the prevention of human cytomegalovirus (CMV) infection in patients receiving bone marrow transplant. Language: English Contact: MerckMedia:Caroline Lappetito, 267-305-7639orInvestors:Carol Ferguson, 908-423-4465orAiCurisMedia:Katja Woestenhemke, +49-202-317-63-1176 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
publication
journal
agent
Sites : [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] next »